Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Lupin to sell its stake in Kyowa to Unison for $526m
Lupin has signed a definitive agreement to sell the entire stake in its Japanese subsidiary Kyowa Pharmaceutical to Unison, a Japanese private equity fund, for JPY57.36bn ($526m).
Manufacturing
-
13 Nov 2019
-
06 Nov 2019
Japan’s Takeda opens dengue vaccine manufacturing facility in Germany
Japan-based Takeda Pharmaceutical has opened a new dengue vaccine manufacturing facility in Singen, Germany.
-
05 Nov 2019
Samsung Biologics and Ichnos Sciences announce agreement for manufacture of ISB 830
Samsung Biologics announced the signing of a long-term agreement with Ichnos Sciences for manufacturing drug substance for ISB 830, an anti-OX40 monoclonal antibody in development as a potential treatment for moderate-to-severe atopic dermatitis.
-
22 Oct 2019
Knight Therapeutics to acquire Latin American pharma firm Biotoscana
Knight Therapeutics plans to acquire Brazilian pharma company Biotoscana Investments (GBT) for a price of around BRL1.16bn ($281m), which includes the latter’s financial debt.
-
21 Oct 2019
Sartorius Stedim to buy certain life science businesses of Danaher for $750m
Sartorius Stedim Biotech has agreed to acquire some of the life science businesses of US conglomerate Danaher for around $750m.
-
17 Oct 2019
TriPharm Services announces creation of pharmaceutical manufacturing center
TriPharm Services, a new contract development and manufacturing organization (CDMO), is commissioning a new specialized manufacturing operation utilizing the latest isolator manufacturing equipment.
-
15 Oct 2019
Thermo Fisher launches IonicX XRF Analyzer to identity ionic salts
Thermo Fisher Scientific has launched a new handheld X-ray fluorescence analyser called IonicX XRF Analyzer to help pharmaceutical and biopharmaceutical manufacturers to verify the identity of ionic salts in warehouses within seconds.
-
22 Aug 2019
Pfizer to invest £411m in new US gene therapy manufacturing facility
Pfizer is set to invest an additional $500m (£411m) to build an advanced gene therapy manufacturing facility in Sanford, North Carolina, US.
-
17 Jul 2019
Kite to bolster cell therapy manufacturing capabilities with new viral vector facility
Kite, a Gilead Company (Nasdaq: GILD), today announced plans for a new 67,000-square-foot facility in Oceanside, California, dedicated to the development and manufacturing of viral vectors, a critical starting material in the production of cell therapies.
-
11 Jul 2019
Nexus Pharmaceuticals to build sterile injectable production facility in Wisconsin
US-based healthcare firm Nexus Pharmaceuticals is set to construct a new sterile injectable manufacturing facility in Wisconsin, US.